Brage Storstein Andresen

Search results

• 2023

  Allele specific splice switching oligonucleotides targeting pseudoexons

  Andresen, B. S. (Inventor), Doktor, T. K. (Inventor), Holm, L. L. (Inventor), Petersen, U. S. S. (Inventor) & Bruun, G. H. (Inventor), 3. Aug 2023, IPC No. A61K31/7088, C12N15/11, C12N15/113, Patent No. WO2023144263 (A3), Priority date 26. Jan 2022, Priority No. DK2022PA70346

  Research output: Patent

  • Allele 100%
  • Oligonucleotide 100%
  • Precursor mRNA 25%
  • Messenger RNA 25%

• Splice shifting oligonucleotides for use in the treatment of diseases characterized by altered inclusion of microexons

  Ruíz Desviat, L. (Inventor), Martínez Pizarro, A. (Inventor), Lucas Lozano, J. J. (Inventor), Picó Del Pino, S. (Inventor) & Andresen, B. S. (Inventor), 13. Apr 2023, IPC No. C12N15/113, Patent No. WO2023057575, Priority date 7. Oct 2021, Priority No. EP20210382898

  Research output: Patent

  • Disease 100%
  • Oligonucleotide 100%
  • Neurologic Disease 50%
  • Binding Site 50%
  • Pervasive Developmental Disorder 50%

• Splice switching oligonucleotides pseudoexons

  Andresen, B. (Inventor), Doktor, T. (Inventor), Holm, L. (Inventor), Petersen, U. S. S. (Inventor) & Bruun, G. (Inventor), 10. Aug 2023, IPC No. A61K31/7088, C12N15/11, C12N15/113, Patent No. AU2022213196 (A1), Priority date 26. Jan 2021, Priority No. WO2022EP51790

  Research output: Patent

  • Oligonucleotide 100%
  • Precursor mRNA 33%
  • Messenger RNA 33%
• 2015

  RAS Exon 2 Skipping for Cancer Treatment

  Andresen, B. S. (Inventor), 25. Jun 2015, Patent No. WO2015091525 (A1), 25. Jun 2015, Priority date 16. Dec 2013, Priority No. DK20130070774

  Research output: Patent